Relay Therapeutics, Inc.
Developing precision medicines for oncology & genetic diseases by analyzing protein motion.
RLAY | NDAQ
Overview
Corporate Details
- ISIN(s):
- US75943R1023
- LEI:
- Country:
- United States of America
- Address:
- 60 HAMPSHIRE STREET, 2139 CAMBRIDGE
- Website:
- https://relaytx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Relay Therapeutics, Inc. is a clinical-stage precision medicines company that is transforming the drug discovery process. The company utilizes its proprietary Dynamo® platform, which integrates advanced computational and experimental methods to gain unparalleled insights into protein motion. This approach enables the company to pursue previously intractable or inadequately drugged targets. Relay Therapeutics is advancing a pipeline of promising therapeutic candidates with an initial focus on precision oncology and genetic diseases, aiming to create life-changing medicines for patients with serious conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Relay Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Relay Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Relay Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
